Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05098652 · ClinicalTrials.gov registry record · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
A NA study of Dementia and Care-resistant Behavior, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 1
- Study location
NCT05098652: Recruiting NA study of Dementia and Care-resistant Behavior, sponsored by University of Alabama at Birmingham.
NCT05098652 is a NA study of Dementia and Care-resistant Behavior that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 266 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05098652, a NA study of Dementia and Care-resistant Behavior, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 1
- Study location
Study Summary
266 family caregivers will be randomly assigned to either immediate intervention or delayed intervention groups. All caregivers will complete baseline surveys and 3 weeks of daily diaries. The immediate intervention group will receive 12 weeks of CuRB-IT. They will complete 3 rounds of 3-week daily diaries followed by an intermittent survey at 12 week intervals for the next 33 weeks. The delayed intervention group will receive 12 weeks of attention, complete 1 round of 3-week daily diaries followed by an intermittent survey, then complete 12 weeks of CuRB-IT, and complete 2 rounds of 3--week daily diaries followed by an intermittent survey at 12-week intervals for the next 18 weeks.
Primary Outcome
Experimental and control
Conditions Studied
Interventions
- BEHAVIORAL CuRB-IT
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT05098652 shows while recruiting
NCT05098652 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which CuRB-IT is the first listed.
NCT05098652 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05098652 about?
NCT05098652 is a clinical study titled "Coaching Dementia Caregivers to Master Care-Resistant Behavior". 266 family caregivers will be randomly assigned to either immediate intervention or delayed intervention groups. All caregivers will complete baseline surveys and 3 weeks of daily diaries. The immediate intervention group will receive 12 weeks of CuRB-IT. They will complete 3 rounds of 3-week daily ...
What is the current status of trial NCT05098652?
This trial is currently recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2023-04-01. Estimated completion is 2027-09-30.
What conditions does trial NCT05098652 study?
This clinical trial studies the following conditions: Dementia, Care-resistant Behavior.
What interventions are being tested in trial NCT05098652?
The interventions under investigation include: CuRB-IT (BEHAVIORAL).
Who is sponsoring clinical trial NCT05098652?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05098652 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05098652's enrollment target sits among peer trials
266 79th of 199 higher than 121 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
- NCT06560866 · 266 participants · NA
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI